Welcome to our dedicated page for Houlihan Lokey news (Ticker: HLI), a resource for investors and traders seeking the latest updates and insights on Houlihan Lokey stock.
Houlihan Lokey, Inc. (NYSE: HLI) is a prominent global investment bank renowned for its expertise in mergers and acquisitions (M&A), capital markets, valuation, financial restructuring, and strategic consulting. Serving a diverse clientele that includes corporations, institutions, and governments, the firm operates from offices strategically located across the United States, Europe, and the Asia-Pacific region.
Houlihan Lokey’s operations are segmented into three core business units:
- Corporate Finance: Specializes in providing M&A and capital markets advisory services, helping clients navigate complex transactions and achieve their financial goals.
- Financial Restructuring: Known for advising on some of the most intricate restructuring deals globally, this segment is instrumental in guiding clients through financial distress and turnaround situations.
- Financial and Valuation Advisory Services: Offers comprehensive valuation, financial opinion, and strategic consulting services, ensuring clients receive independent and intellectually rigorous advice.
The firm's dedication to independent advice and intellectual rigor has made it a trusted partner in the financial sector. Houlihan Lokey is consistently ranked as a top advisor in various categories. According to Thomson Reuters, the firm holds the title of the No. 1 M&A advisor for U.S. transactions under $5 billion, the No. 1 M&A fairness opinion advisor for U.S. transactions over the past decade, and the No. 1 global restructuring advisor.
Recent achievements include strategic partnerships and successful advisory roles in high-profile transactions, further solidifying its reputation as a leader in investment banking. The company continues to expand its global footprint and enhance its service offerings, ensuring it remains at the forefront of the industry.
For more detailed information, visit the official website at www.hl.com.
Houlihan Lokey (NYSE:HLI) has appointed Sameer Shamsi as Managing Director and Head of Secondaries in its Private Funds Group, based in New York. Shamsi, previously with Credit Suisse, brings extensive experience in secondary advisory, having led various innovative transactions for alternative asset managers. His appointment aims to strengthen Houlihan Lokey's secondary market capabilities amid its growth. The firm has raised $8.2 billion in private placements since 2015 and is ranked highly in M&A and restructuring advisory.
Houlihan Lokey (NYSE:HLI) reported robust financial results for the fiscal year and Q4 ended March 31, 2021. Revenue surged 32% to a record $1.53 billion, with Q4 revenue up 65% to $501 million. Net income rose to $313 million ($4.55 per diluted share), a significant increase from $184 million ($2.80 per diluted share) in the previous year. Adjusted net income also climbed 51% to $317 million. Key drivers included increases in Corporate Finance revenues by 24%, Financial Restructuring by 52%, and Valuation Advisory by 17% for the fiscal year. A quarterly cash dividend of $0.43 was declared.
Houlihan Lokey (NYSE:HLI) announced the hire of Jonathan Guskind as Managing Director in the Healthcare Group, focusing on medical technology. Previously at Morgan Stanley, Guskind brings over a decade of experience in healthcare investment banking. His addition follows recent expansions in Houlihan Lokey's healthcare team, positioning the firm among the largest medtech-focused groups globally. The firm's Healthcare Group was ranked as the No. 1 M&A advisor for U.S. healthcare transactions under $1 billion in 2020, indicating its strong market presence and commitment to client success.
Houlihan Lokey (NYSE:HLI) has launched its European oil and gas sector coverage by hiring a seasoned team from BMO Capital Markets, led by Jeremy Low as Managing Director. The team, based in London, brings a wealth of experience, having advised on over $20 billion in M&A and raised over $3.8 billion in capital in the last four years. This expansion reflects Houlihan Lokey's strategic growth in corporate finance across seven industry sectors in Europe, building on recent acquisitions and sector-specific expertise.
Houlihan Lokey (NYSE:HLI) will announce its fiscal 2021 Q4 and full year results on May 11, 2021, post market close. CEO Scott Beiser and CFO Lindsey Alley will discuss performance on a conference call at 5:00 p.m. (ET), followed by a Q&A session. Investors can participate through a dedicated phone line or via an audio webcast on the company's website. A replay of the call will be available until May 18, 2021. The firm remains a leader in M&A and restructuring advisory, having achieved top rankings in transaction volume according to Refinitiv's data.
Houlihan Lokey (NYSE:HLI) announced the expansion of its Healthcare Group into Europe with two key appointments: Paul Tomasic as Managing Director and Head of European Healthcare, and Andrew Murray-Lyon as Director, both based in London. Their addition aims to leverage the firm's strong US healthcare expertise to benefit European clients. Over the past six years, Houlihan Lokey's European Corporate Finance business has grown significantly, now employing over 260 bankers. The Healthcare Group, ranked No. 1 for U.S. healthcare M&A transactions under $1 billion, aims for continued growth in the mid-cap advisory space.
Houlihan Lokey (NYSE:HLI) has appointed Dr. Andreas Dombret as Independent Chairman for its operations in Germany, Austria, and Switzerland (DACH). Initially a Senior Advisor, Dombret will now enhance leadership in Corporate Finance and Financial Restructuring, facilitating the firm's expansion in the region. His previous experience includes roles at the Deutsche Bundesbank and European Central Bank. The firm is also set to relocate its German offices to Frankfurt in April, marking a significant step in its growth strategy.
Houlihan Lokey (NYSE:HLI) reported strong financial results for Q3 ended December 31, 2020, with revenues reaching $538 million, up from $334 million year-over-year. Net income was $119 million, or $1.71 per diluted share, compared to $49 million, or $0.75 per diluted share in Q3 2019. Key segments showed substantial growth: Corporate Finance up 52%, Financial Restructuring up 92%, and Financial and Valuation Advisory up 36%. The cash dividend was declared at $0.33 per share, and the share repurchase program increased by $75 million.
Houlihan Lokey (NYSE:HLI) will release its third quarter results for the fiscal year 2021 on January 28, 2021, post-market. A conference call is scheduled for 5:00 p.m. (ET) to discuss the results, featuring Scott Beiser, CEO, and Lindsey Alley, CFO. Participants can access the call via telephone or audio webcast. The call will also be available for playback from 8:00 p.m. (ET) the same day until February 4, 2021. Houlihan Lokey is recognized as a top M&A advisor and restructuring advisor, solidifying its leadership in the global investment banking sector.
Houlihan Lokey (NYSE:HLI) announced that CEO Scott Beiser will present at Goldman Sachs’ 2020 US Financial Services Conference on December 8, 2020, at 3:00 p.m. Eastern Time. The presentation will be available via live webcast on the company’s website, www.hl.com, with a replay archived for later access. Houlihan Lokey is a leading global investment bank known for its expertise in M&A, capital markets, financial restructuring, and valuation. The firm has maintained its position as the top M&A advisor in the U.S. for five consecutive years, according to Refinitiv data.
FAQ
What is the current stock price of Houlihan Lokey (HLI)?
What is the market cap of Houlihan Lokey (HLI)?
What services does Houlihan Lokey, Inc. provide?
Where are Houlihan Lokey's offices located?
Who are the clients of Houlihan Lokey?
What are the core business segments of Houlihan Lokey?
What rankings does Houlihan Lokey hold?
How does Houlihan Lokey ensure client success?
What is Houlihan Lokey known for in the M&A sector?
What recent achievements has Houlihan Lokey made?
What is the significance of Houlihan Lokey's Financial Restructuring segment?
Where can more information about Houlihan Lokey be found?
